コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 - (22 recipients from D- with false positive HIV tests).
2 infection, and a positive fourth-generation HIV test.
3 g), or by the child's caregiver with an oral HIV test.
4 tudy drug and had at least one post-baseline HIV test.
5 947 FSWs initially seen in clinic, 692 were HIV tested.
6 ion; participants completed an interview and HIV testing.
7 s was ascertained through medical records or HIV testing.
8 als aged 16 years or older were eligible for HIV testing.
9 A total of 3301 youths underwent HIV testing.
10 th clinic/pharmacy), or (3) standard-of-care HIV testing.
11 sufficient to achieve universal coverage of HIV testing.
12 ss to follow-up and death at 12 months after HIV testing.
13 visits, as HIVST can replace other types of HIV testing.
14 of study outcomes and overall high uptake of HIV testing.
15 healthcare facility, or (3) standard of care HIV testing.
16 ty values for pediatric, including neonatal, HIV testing.
17 stigma, mental health, sexual behavior, and HIV testing.
18 with stable residence 104,635 (99%) accepted HIV testing.
19 e, HIV prevalence, condom use, and uptake of HIV testing.
20 with HIV were tested during population-level HIV testing.
21 le-up in settings with a high unmet need for HIV testing.
22 ween lower stigma predicting higher rates of HIV testing.
23 s was ascertained through medical records or HIV-testing.
24 volve frequent human immunodeficiency virus (HIV) testing.
25 y [IGRA]), and human immunodeficiency virus (HIV) testing.
26 Of 12 769 individuals who were eligible for HIV testing, 12 407 (97.2%) accepted testing, including
27 combined effect of test and treat and annual HIV testing (61.8%, IQR 47.2-81.8, of total incidence) w
28 2), mean time to ART initiation from time of HIV testing (7 days versus 14 days, p < 0.001), viral su
29 I 23.2-35.4) of participants had no previous HIV testing (adjusted from 60 participants), 31.2% (18.8
34 adults not consenting to the intervention or HIV testing, although our conclusions were robust in sen
35 esting (HIVST) interventions on frequency of HIV testing among Chinese MSM and their sexual partners.
36 s significantly more effective in increasing HIV testing among FSWs than passively offering HIV self-
38 nalyses showed that the likelihood of taking HIV testing among intervention participants were 2.1 tim
39 al relationships of perceived HIV stigma and HIV testing among men and women living in rural Uganda.
42 Facility-based HIV self-testing increased HIV testing among outpatients in Malawi, with a minimal
43 V-1 RNA < 1,000 copies/mL at 12 months after HIV testing among patients on ART >/=6 months, and loss
44 of HIV infection was successful in promoting HIV testing among their sexual partners and in facilitat
46 Although integrated care centres increased HIV testing among visitors, our low exposure findings su
49 ed to increase human immunodeficiency virus (HIV) testing among men who have sex with men and transge
50 ssociated with human immunodeficiency virus (HIV) testing among people who inject drugs (PWID) in rur
51 nique opportunity to also conduct widespread HIV testing, among other health-promotion activities.
55 rates of patient attrition from care between HIV testing and antiretroviral therapy (ART) initiation
56 and infants received antenatal and postnatal HIV testing and antiretroviral therapy per local guideli
57 l of standard ART initiation versus same-day HIV testing and ART initiation among eligible adults >/=
64 isted partner services are safe and increase HIV testing and case-finding; implementation at the popu
65 isted partner services are safe and increase HIV testing and case-finding; implementation at the popu
67 villages in the intervention group received HIV testing and counseling, linkage to care, ART (starte
69 ART] initiation for all [including increased HIV testing and counselling activities], and oral pre-ex
70 r $5 or $10 if the participant presented for HIV testing and counselling at a local primary health-ca
71 social network intervention was superior to HIV testing and counselling in affecting HIV incidence a
74 re given an invitation card for clinic-based HIV testing and encouraged to distribute the card to the
75 to assess the effect of such legislation on HIV testing and engagement with the HIV treatment cascad
78 is study, we aimed to describe the uptake of HIV testing and linkage to care and treatment during thi
81 ave contributed to increased rates of infant HIV testing and maternal retention in care at both inter
83 ity sensitisation and PrEP education, we did HIV testing and offered PrEP at health fairs and facilit
84 self-testing that merit its integration into HIV testing and prevention systems in the United States.
85 c of HIV treatment programme failure; timely HIV testing and rapid linkage to care remain an urgent p
86 T legislation might be associated with lower HIV testing and status awareness; therefore, further res
87 measures and programmes that further expand HIV testing and support disclosure of HIV status are nee
89 o the availability of comprehensive baseline HIV testing and the rapid expansion of ART eligibility i
90 V care and prevention service, but uptake of HIV testing and thus coverage of antiretroviral therapy
91 y (OAT), needle and syringe programs (NSPs), HIV testing and treatment (Test & Treat), and oral HIV p
92 hanges in the engagement of African MSM with HIV testing and treatment cascade stages over time, and
97 le to achieve very high population levels of HIV testing and treatment in a high-prevalence setting.
98 mmes face challenges achieving high rates of HIV testing and treatment needed to optimise health and
100 of a patient-centred approach to streamlined HIV testing and treatment that could help China change t
102 uptake and engagement after population-level HIV testing and universal PrEP access to characterise ga
105 ith additional provider training and morning HIV testing), and facility-based HIV self-testing (Oraqu
106 of male condom use, adult male circumcision, HIV testing, and early antiretroviral therapy (ART).
107 e standard group initiated ART 3 weeks after HIV testing, and the same-day group initiated ART on the
108 tify socioeconomic inequalities in uptake of HIV testing, and to establish trends in testing uptake i
109 is a formidable social structural barrier to HIV testing, and yet the effect of stigma on HIV testing
110 a cluster-randomised controlled trial of an HIV test-and-treat strategy in 32 rural communities in U
111 e HIV care continuum : We evaluated enhanced HIV testing (annual for high-risk groups), increased 3-m
112 efore and were willing to undergo home-based HIV testing, answer demographic and behavioural question
113 to show the effectiveness of a hybrid mobile HIV testing approach at achieving population-wide testin
114 testing saturation, we implemented a hybrid HIV testing approach in an urban informal settlement in
115 that community-based targeted approaches to HIV testing are more effective than universal screening
116 nvincing evidence that currently recommended HIV tests are highly accurate in diagnosing HIV infectio
120 rcourse in the previous 3 months, a negative HIV test at baseline, and a negative HIV test in the pre
121 ied primary outcomes were self-report of any HIV testing at 1 month and at 4 months; our prespecified
125 The mean absolute difference in uptake of HIV testing between the richest and poorest participants
126 ients presenting for any HIV care, including HIV testing, but not yet on ART were enrolled and random
127 ughout the programme coverage area, at which HIV testing by certified testing service counsellors was
129 ery-based incentives increased the uptake of HIV testing by older children and adolescents, a key har
132 re needed to improve access to and uptake of HIV testing, care, and treatment, and management of non-
134 included 14 structured questions focusing on HIV testing, cluster of differentiation 4 (CD4) testing,
135 rategies, including test-and-treat (expanded HIV testing combined with immediate treatment) and PrEP
136 f infants in the intervention group received HIV testing compared with the control group, but the dif
137 munity health campaigns (CHCs) that included HIV testing, counselling, and referral to care if HIV in
139 HIVST) may play a role in addressing gaps in HIV testing coverage and as an entry point for HIV preve
141 y among Chinese MSM and effectively enlarged HIV testing coverage by enhancing partner HIV testing th
142 ey in 2011-12 to the last survey in 2016-17, HIV testing coverage increased from 68% (2613 of 3870) t
146 Disease Control and Prevention (CDC)-funded HIV testing data submitted by 61 health departments and
147 ention comprises annual rounds of home-based HIV testing delivered by community HIV-care providers (C
148 prevention intervention included home-based HIV testing delivered by community workers, who also sup
149 atitis (VH) or human immunodeficiency virus (HIV) testing despite high prevalence among OTP clients.
150 the 2.5-year intervention, BCPE did 133 695 HIV tests, diagnosed and linked 3918 people living with
151 er or not assisted partner services increase HIV testing, diagnoses, and linkage to care among sex pa
154 treatment interventions, including enhanced HIV testing, earlier antiretroviral therapy (ART), and s
157 uding status quo; a 1-time HIV test; routine HIV testing every 3, 6, or 12 months; and PrEP with HIV
158 tion phase, integrated care centres provided HIV testing for 14 698 unique clients (7630 PWID and 706
159 re offered facility-based or community-based HIV testing for children (age 2-18 years) living in thei
162 mpleted interviews that included measures of HIV testing history and how participants perceived HIV s
163 on included sexual behaviour questionnaires, HIV testing (HIV-negative partner), and HIV-1 viral load
164 ges: three population stages (first positive HIV test, HIV status knowledge, and linkage to care) and
165 be important venues for rural PWID to access HIV testing; however, testing services should be offered
166 31) to 24% (25 of 106; p=0.01), while recent HIV testing (ie, in the past year) increased from 26% (2
167 offering same-day (SD) ART during home-based HIV testing improved engagement in care and viral suppre
168 agnostics since the development of the first HIV test in the mid-1980s, targets such as nucleic acids
169 were less likely than older MSM to report an HIV test in the past year (PR 0.88, 0.78-0.98), recent p
172 n addition to provider-initiated and opt-out HIV testing in adolescents, Sheri Weiser and colleagues
173 We demonstrate a dramatic improvement in HIV testing in children with TB over time and excellent
174 , we examine trends in sexual behaviours and HIV testing in MSM and explore the risk of transmitting
177 tive socioeconomic inequalities in uptake of HIV testing in sub-Saharan Africa has decreased, absolut
178 d to a questionnaire and had blood drawn for HIV testing in the absence of documentation of positive
179 The primary outcome was any self-reported HIV testing in the past month at the 1- and 4-month visi
182 roportions of participants who had undergone HIV testing in the previous 12 months across wealth and
183 socioeconomic inequalities in the uptake of HIV testing in the previous 12 months decreased in male
184 ts than male participants reported uptake of HIV testing in the previous 12 months in five of 16 coun
185 5% CI 1.42-5.40) times more likely to report HIV testing in the previous 12 months than were the poor
188 partners were 1.55 times more likely to take HIV tests in the intervention arm compared with the cont
192 HIV testing, and yet the effect of stigma on HIV testing is rarely examined at the community level.
196 the trial and report on uptake of home-based HIV testing, linkage to care, uptake of ART, and communi
197 of condom use during sex acts, acceptance of HIV testing, linkage to health care, criteria for ART in
198 ollection, provision of injection equipment, HIV testing, linkage to opioid substitution treatment (O
199 BCPE findings suggest scaling up recommended HIV testing, linkage, and retention interventions can he
201 ondary outcomes were uptake of the different HIV testing methods, HIV yield (proportion of eligible c
204 hese guidelines date back to an era in which HIV testing of infants was impossible and mothers had po
205 July 15, 2019, 31 239 individuals underwent HIV testing, of whom 930 (3%) tested positive for HIV.
206 7 patients in the HIV self-testing group had HIV testing on the same day as enrolment, compared with
207 and to choose between different hypothetical HIV testing options, including the option not to test.
209 , non-pregnant patients receiving a positive HIV test or first treatment-eligible CD4 count were rand
210 ted benefits of ART initiation on the day of HIV testing or at first clinical visit, regardless of CD
211 More than 85% of patients presenting for HIV testing or care, including those newly diagnosed, we
212 Organization recommends PrEP with quarterly HIV testing, our analysis identifies PrEP with semiannua
217 Self-reported VMMC status was collected and HIV tests performed at surveys conducted every 18 months
218 centres in India that provided single-venue HIV testing, prevention, and treatment services for peop
220 We assessed PrEP uptake within 90 days of HIV testing, programme engagement (follow-up visit atten
222 ting program designed to encourage localized HIV testing programs focused on self-identified sexual m
224 stem) to be efficacious for improving infant HIV testing rates and maternal retention in prevention o
225 t are appropriately implemented can increase HIV testing rates and voluntary male circumcision, and t
229 ntion package including universal home-based HIV testing, referral of HIV-positive individuals to gov
231 ple in the control population had a positive HIV test result (crude prevalence 3.9%, 95% CI 2.9-5.3)
232 ner who attended the clinic with a confirmed HIV test result were $23.73 and $28.08 for the HIVST + $
234 POC EID improves the speed of return of HIV test results and enables earlier ART initiation; thi
235 testing providers for interpreting negative HIV test results obtained shortly after exposure, and fo
236 medical history, chest imaging results, and HIV test results were recorded at enrolment, and each pa
237 for MSM/PWID, including status quo; a 1-time HIV test; routine HIV testing every 3, 6, or 12 months;
238 0.55), loss to follow-up at 12 months after HIV testing (RR 0.56, 95% CI 0.40-0.79, p = 0.002), and
240 1.57, p < 0.001) but did not improve repeat HIV testing (RR 1.00, 95% CI 0.88 to 1.13, p = 0.958).
241 in the control arm had access to site-based HIV testing (SBHT); those in the intervention arm were p
242 l HIV self-testing plus routine door-to-door HIV testing services (HIV self-testing group) or the Pop
243 the PopART standard of care of door-to-door HIV testing services alone (non- HIV self-testing group)
247 self-testing during delivery of door-to-door HIV testing services increased knowledge of HIV status,
248 rom community health campaigns that included HIV testing services or at a local government health fac
249 uster-randomised trial provided door-to-door HIV testing services to a large proportion of individual
250 clusters) in four districts receiving mobile HIV testing services were randomly assigned (1:1) to inc
255 t-forward model with standard of care at two HIV testing sites for MSM in Guangzhou, China: an STD cl
256 r results emphasize the need for appropriate HIV testing strategies before and possibly shortly after
259 ting HIV interventions that require frequent HIV testing, such as HIV treatment as prevention, behavi
261 and the secondary outcome was the number of HIV tests taken by their sexual partners during 12 month
262 mpt to comprehensively gather information on HIV testing technology coverage in WHO Member States.
263 uring 2014-20, including increasing rates of HIV testing, test-and-treat programmes, pre-exposure pro
266 are centre were more likely to report recent HIV testing than were participants who had not (adjusted
267 t pulse oximetry, nutritional assessment, or HIV testing, then we recommend considering referral to c
268 ed HIV testing coverage by enhancing partner HIV testing through distribution of kits within their se
269 ntemporaneous comparison groups and repeated HIV testing throughout the period of breastfeeding.
272 were not prespecified: self-report of repeat HIV testing-to understand the intervention effects on fr
276 d offered eligible individuals the choice of HIV testing using HIV self-testing or routine door-to-do
278 he primary population-level analysis, recent HIV testing was 31% higher at integrated care centres th
280 gh a caregiver questionnaire, and anonymised HIV testing was carried out using oral mucosal transudat
282 ion arm was validated; the number of partner HIV testing was indirectly reported by participants beca
283 Among 570 participants analyzed, partner HIV testing was more likely in the HIVST group (90.8%, 2
293 f pregnant women living with HIV) and repeat HIV testing (which is necessary to identify and treat wo
296 ds were invited to complete an interview and HIV testing, with one woman per household eligible to an
298 luding persons known to be HIV+ or reporting HIV testing within last 12 months) was implemented using
300 gs such as co-trimoxazole, and suspension of HIV testing would all have a substantial effect on popul